Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment
Abstract Hypothyroidism is a risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD) but it is not clear whether subclinical hypothyroidism (SCH) increases the risk of MASLD and whether SCH patients with MASLD require treatment. In this study, we reviewed articles published...
Prif Awduron: | Sicheng Pu, Binbin Zhao, Yuxuan Jiang, Xuejiao Cui |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
BMC
2025-02-01
|
Cyfres: | Lipids in Health and Disease |
Pynciau: | |
Mynediad Ar-lein: | https://doi.org/10.1186/s12944-025-02474-0 |
Eitemau Tebyg
-
Hypothyroidism, Subclinical Hypothyroidism, High-normal TSH-level
Cyhoeddwyd: (2009-06-01) -
The Risk of Developing Non-Alcoholic Fatty Liver Disease in Adult Patients with Subclinical Hypothyroidism Compared to Euthyroid: An Evidence-based Case Report
gan: Kemas Rakhmat Notariza, et al.
Cyhoeddwyd: (2019-08-01) -
Study of Insulin Resistance in Patients with Subclinical Hypothyroidism
gan: Amr Shehata, et al.
Cyhoeddwyd: (2022-11-01) -
Relationship between Hypothyroidism and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
gan: Weiwei He, et al.
Cyhoeddwyd: (2017-11-01) -
Subclinical hypothyroidism: treat or watch?
gan: I. A. Tsanava, et al.
Cyhoeddwyd: (2021-03-01)